Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BUP TDS vs MOR SR for chronic cancer pain in China
CTR20182192Phase 3Terminated
- Sponsor
- Grünenthal GmbH
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine in cancer pain, sponsored by Grünenthal GmbH. Started Dec 2018; status: terminated.
02
Drugs
buprenorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on CTR20182192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182192.